Skip to main content
Caplight Logo









TendoNova

TendoNova

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://tendonova.com/

Last Round

Debt

Jun 26, 2024

Total Funding Raised

$2.47M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

TendoNova is a medical device company that develops and commercializes micro-invasive tools for orthopedic procedures, such as the FDA-cleared Ocelot system for treating chronic tendon pain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

minimally invasive surgerytendinopathy treatmentorthopedic medical deviceultrasonic tenotomysports medicineminimally invasivetenotomyambulatory surgery centerASCrazor and bladesorthopedic surgerymedical device manufacturerchronic tendon painsurgical instrument

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TendoNova Comparables

Compare TendoNova with similar companies based on industry and business-model similarity.

TendoNova comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HydroCision, Inc.
83%
Trice Medical
80%
Sonex Health
77%

TendoNova Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJun 26, 2024
VC RoundApr 12, 2024
GrantAug 5, 2021
DebtFeb 2, 2021
SeedJun 11, 2020

Key People

Founding team and executive leadership

Brett Rogers

Chief Operating Officer

Executive Team

TendoNova Investors

Notable investors and investment history

TendoNova investors
InvestorRounds
Georgia Research AllianceGrant
Georgia Research AllianceSeed, Grant
NFL Players AssociationSeed
VentureSouthVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2026

    Grew 18% QoQ, from 17 to 20 employees.

  • Jan 24, 2026

    Medical device has received FDA clearance.

TendoNova Filings

Explore SEC and related filing metadata, where available.

TendoNova filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TendoNova's valuation, stock price, and market status.

Is TendoNova a public or private company?

TendoNova is a private company.

What is the current stock price of TendoNova?

TendoNova is a private company with no public stock price. No recent secondary market data is available.

How much is TendoNova worth (valuation)?

Valuation information for TendoNova is not publicly available.

Can I buy TendoNova stock?

TendoNova shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TendoNova's last funding round?

TendoNova's most recent funding round was Debt on June 26, 2024.

Who are the main investors in TendoNova?

Key investors in TendoNova include VentureSouth.

Will TendoNova IPO soon?

No public IPO plans have been announced for TendoNova.

How can I track TendoNova secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TendoNova's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range18
Year Founded2017
Last FundingJun 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?